ICCC CIK: 811641

ImmuCell Corporation

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.95
FY22:
−1.54
FY23:
−4.67
FY24:
0.36
FY25:
2.48
Change from FY21 to FY25
millions USD
FY21:
−1.60
FY22:
−3.96
FY23:
−1.89
FY24:
−0.46
FY25:
−1.21
Change from FY21 to FY25
millions USD
FY21:
3.88
FY22:
1.11
FY23:
1.75
FY24:
2.88
FY25:
−1.21
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
2.78
FY25:
0.05
(positive)
Change from FY21 to FY25
millions USD
FY21:
−1.65
FY22:
−5.52
FY23:
−6.57
FY24:
−0.11
FY25:
1.22

All amounts in millions USD Data source:SEC EDGAR